GSK, Ionis Achieve Functional Cure in Hepatitis B Studies, Clearing Path for FDA Run
Though specific data for bepirovirsen remain under wraps, GSK plans to file for approval in the first quarter of 2026.
GSK, Ionis Achieve Functional Cure in Hepatitis B Studies, Clearing Path for FDA Run Read More »
